Page 15





Dermalux range receives CE mark Aesthetic Technology Ltd, manufacturer of the Dermalux LED systems has received medical CE certification for the Dermalux MD range. According to the company, receiving the CE mark will mean that Dermalux customers will be able to state medical claims for the treatment and management of acne, psoriasis, musculoskeletal pain and wound healing. Cosmetic indications also include rejuvenation, pigmentation and sensitive skin conditions. Managing director, Dale Needham explains, “For our Dermalux MD Range to have achieved Medical CE Certification for the treatment and management of such chronic skin conditions, is fantastic; not just for us as a company but also for our clients and subsequently, thousands of their patients.” Business

3D-lipo Ltd expands team Aesthetic device manufacturer 3D-lipo Ltd has hired Olivia Manuel as its newest business development manager. According to 3D-lipo Ltd, the appointment is due to the success of the company’s Business Development scheme, which launched in May 2019. The company notes that Manuel is a qualified nurse, specialising in plastic surgery and aesthetics, and has more than seven years’ experience within the industry. Manuel will be working throughout the Home Counties, Central and West London, helping 3D-lipo Ltd clinic owners to maximise the success of their clinics. Scott Julian, national sales manager at 3D-lipo Ltd, said, “As a business development manager at 3D-lipo Ltd, Olivia will be available for dedicated appointments to both existing and prospective clients. 3D-lipo Ltd’s Business Development programme gives clients the opportunity to benefit from exclusive updates and insights into all the latest from 3D, including marketing advice, training information as well as face-to-face support, and presenting the latest equipment from 3D-lipo Ltd. We are thrilled to have Olivia on the team.” Dermatology

Almirall calls for partners to develop new dermatology therapies AlmirallShare, a proprietary of Spanish pharmaceutical company Almirall, has launched to aim to find medical professionals to identify, validate or test new treatments for chronic immune-inflammatory diseases of the skin. Diseases to be covered include psoriasis, atopic dermatitis and pemphigus vulgaris, and the call is open until October 31. Scientists in universities, research centres, start-ups, bio-techs or pharmaceutical companies worldwide are all encouraged to to take part. The company will also offer grants of up to €250,000 and scientific support to the selected proposals, it states. “Many chronic immune-inflammatory diseases, irrespective of the organ affected, share common mechanisms, pathways and players. Psoriasis has therapies in common with multiple sclerosis and rheumatoid arthritis; atopic dermatitis with asthma; pemphigus with lupus, to name a few. We would be delighted to explore with our partners a target, pathway or therapy, related to any immune-inflammatory disease, that can be of use on a dermatological indication,” said Nuria Godessart, head of biology at Almirall.

News in Brief Derma-Seal secures stockists Aftercare spray Derma-Seal will now be distributed by medical aesthetic suppliers Wigmore Medical, John Bannon Pharmacy and Church Pharmacy, as well as being available on Amazon. The product was previously only available directly through the Derma-Seal website. Consultant plastic and aesthetic surgeon Mr Dalvi Humzah, one of the product’s developers, said, “We have seen considerable growth in the last six months, with many clinics using Derma-Seal post injection to prevent infection, and I am confident that working with these pharmacies will accelerate this growth.” CoolSculpting celebrates 10-year anniversary The non-surgical fat reduction treatment CoolSculpting is celebrating 10 years since receiving market approval in 30 countries on September 12. According to the company, more than seven million treatments have been completed worldwide. Nancy Ghattas, associate vice president UK and Ireland country manager at Allergan said, “We’re delighted to be celebrating this iconic milestone. It is a true pioneering and marketleading brand, with over seven million treatments performed globally.” IAPCAM to hold complications course in September The International Association for Prevention of Complications in Aesthetic Medicine (IAPCAM) is holding a fresh cadaver wet lab course the day before its conference in September. The one-day course, titled Anatomical Basis of Facial Rejuvenation with Dermal Fillers And Management of Complications Wet Lab, will take place on Thursday September 19, the day before the IAPCAM conference on Friday September 20 at St George’s University of London in Tooting. Sally Durant Training correction In the August issue of Aesthetics, it was reported that Sally Durant Training had gone into administration. The director of Skin Group (Training) Ltd, has advised this was incorrect. The assets of the company were acquired by Skin Group (Training) Ltd, part of Skin Group International, on June 21. She said, “Skin Group will continue to deliver the Sally Durant courses and we have been in touch with all students that have paid in full about completing courses in progress.” She also confirmed that the Confederation of International Beauty Therapy and Cosmetology (CIBTAC) has approved this arrangement. Aesthetics apologises for any confusion caused to Sally and Skin Group.

Reproduced from Aesthetics | Volume 6/Issue 10 - March 2019

Profile for Aesthetics Journal

Aesthetics September 2019  


Aesthetics September 2019